Literature DB >> 14743663

Human leptospirosis: a twenty-nine-year serological study in São Paulo, Brazil.

Eliete Caló Romero1, Carla Cristiane da Motta Bernardo, Paulo H Yasuda.   

Abstract

A retrospective study of 9,335 cases of human leptospirosis in the state of São Paulo, Brazil, diagnosed between 1969 and 1997 showed that the disease is endemic throughout the state. Middle-aged adults, with a range of 20-39 years, were most frequently infected (32.40%). The mean annual incidence was 0.53 per 100,000 population and the disease was more frequent in males (87.0%). Cases occurred mainly in January to April each year. A peak was observed in 1991 and 1996 which rainfall average was 159.9 and 160.3, respectively. These data emphasize the potential public health importance of leptospirosis in the state of São Paulo, Brazil.

Entities:  

Mesh:

Year:  2003        PMID: 14743663     DOI: 10.1590/s0036-46652003000500002

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  28 in total

1.  Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis.

Authors:  Julio Croda; João G R Ramos; James Matsunaga; Adriano Queiroz; Akira Homma; Lee W Riley; David A Haake; Mitermayer G Reis; Albert I Ko
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

2.  Evaluation of four whole-cell Leptospira-based serological tests for diagnosis of urban leptospirosis.

Authors:  Alan J A McBride; Balbino L Santos; Adriano Queiroz; Andréia C Santos; Rudy A Hartskeerl; Mitermayer G Reis; Albert I Ko
Journal:  Clin Vaccine Immunol       Date:  2007-07-25

3.  Analysis of multilocus sequence typing for identification of Leptospira isolates in Brazil.

Authors:  E C Romero; R M Blanco; R L Galloway
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

4.  Molecular epidemiology of leptospirosis in northern Iran by nested polymerase chain reaction/restriction fragment length polymorphism and sequencing methods.

Authors:  Sedigheh Zakeri; Neda Sepahian; Mandana Afsharpad; Behzad Esfandiari; Peyman Ziapour; Navid D Djadid
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

Review 5.  A global research agenda for leptospirosis.

Authors:  E R Cachay; J M Vinetz
Journal:  J Postgrad Med       Date:  2005 Jul-Sep       Impact factor: 1.476

6.  Evaluation of the EIE-IgM-Leptospirose assay for the serodiagnosis of leptospirosis.

Authors:  Alan J A McBride; Fernanda A Pereira; Emilson D da Silva; Rosan B de Matos; Edimilson D da Silva; Antônio G P Ferreira; Mitermayer G Reis; Albert I Ko
Journal:  Acta Trop       Date:  2007-05-22       Impact factor: 3.112

7.  Genome features of Leptospira interrogans serovar Copenhageni.

Authors:  A L T O Nascimento; S Verjovski-Almeida; M A Van Sluys; C B Monteiro-Vitorello; L E A Camargo; L A Digiampietri; R A Harstkeerl; P L Ho; M V Marques; M C Oliveira; J C Setubal; D A Haake; E A L Martins
Journal:  Braz J Med Biol Res       Date:  2004-03-23       Impact factor: 2.590

8.  Carriage of Leptospira interrogans among domestic rats from an urban setting highly endemic for leptospirosis in Brazil.

Authors:  Marcos Tucunduva de Faria; Michael S Calderwood; Daniel A Athanazio; Alan J A McBride; Rudy A Hartskeerl; Martha Maria Pereira; Albert I Ko; Mitermayer G Reis
Journal:  Acta Trop       Date:  2008-07-31       Impact factor: 3.112

9.  Genetic diversity of the Leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp.

Authors:  Alan J A McBride; Gustavo M Cerqueira; Marc A Suchard; Angela N Moreira; Richard L Zuerner; Mitermayer G Reis; David A Haake; Albert I Ko; Odir A Dellagostin
Journal:  Infect Genet Evol       Date:  2008-11-06       Impact factor: 3.342

10.  Using death certificate reports to find severe leptospirosis cases, Brazil.

Authors:  Anne Spichler; Daniel Athanazio; Marcia Buzzar; Bronislawa Castro; Erica Chapolla; Antonio Seguro; Joseph M Vinetz
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.